These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18464044)

  • 1. A genomic "roadmap" to "better" drugs.
    Liao G; Zhang X; Clark DJ; Peltz G
    Drug Metab Rev; 2008; 40(2):225-39. PubMed ID: 18464044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying genomic and developmental causes of adverse drug reactions in children.
    Becker ML; Leeder JS
    Pharmacogenomics; 2010 Nov; 11(11):1591-602. PubMed ID: 21121777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Variation and Pharmacokinetics in Old Age: A Quantitative Review of Age- vs. Genotype-Related Differences.
    Dücker CM; Brockmöller J
    Clin Pharmacol Ther; 2019 Mar; 105(3):625-640. PubMed ID: 29498032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.
    Nebert DW; Zhang G; Vesell ES
    Drug Metab Rev; 2008; 40(2):187-224. PubMed ID: 18464043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics in drug discovery and development. Preface.
    Yan Q
    Methods Mol Biol; 2008; 448():v-vii. PubMed ID: 18453067
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacogenomics: the promise of personalized medicine.
    Mancinelli L; Cronin M; Sadée W
    AAPS PharmSci; 2000; 2(1):E4. PubMed ID: 11741220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.
    Trent RJ; Cheong PL; Chua EW; Kennedy MA
    Pathology; 2013 Jun; 45(4):357-70. PubMed ID: 23594690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
    Lauschke VM; Ingelman-Sundberg M
    Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics in Alzheimer's disease.
    Cacabelos R
    Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding pharmacogenetics to the clinical laboratory: narrow therapeutic index medications as a place to start.
    Bukaveckas BL
    Arch Pathol Lab Med; 2004 Dec; 128(12):1330-3. PubMed ID: 15578874
    [No Abstract]   [Full Text] [Related]  

  • 11. Dosing recommendations for pharmacogenetic interactions related to drug metabolism.
    Filipski KK; Pacanowski MA; Ramamoorthy A; Feero WG; Freedman AN
    Pharmacogenet Genomics; 2016 Jul; 26(7):334-9. PubMed ID: 27058883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics: translating functional genomics into rational therapeutics.
    Evans WE; Relling MV
    Science; 1999 Oct; 286(5439):487-91. PubMed ID: 10521338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care.
    Lazaridis KN
    Clin Pharmacol Ther; 2017 Jan; 101(1):39-41. PubMed ID: 27804107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of microarrays and biochips in pharmacogenomics.
    Hardiman G
    Methods Mol Biol; 2008; 448():21-30. PubMed ID: 18370228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics/genomics and drug effects.
    Heller F
    Acta Clin Belg; 2013; 68(2):77-80. PubMed ID: 23967712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of pharmacoeconomic studies of pharmacogenomic tests.
    Beaulieu M; de Denus S; Lachaine J
    Pharmacogenomics; 2010 Nov; 11(11):1573-90. PubMed ID: 21121811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of germline and somatic missense variations on drug binding sites.
    Yan C; Pattabiraman N; Goecks J; Lam P; Nayak A; Pan Y; Torcivia-Rodriguez J; Voskanian A; Wan Q; Mazumder R
    Pharmacogenomics J; 2017 Mar; 17(2):128-136. PubMed ID: 26810135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cost-effectiveness analysis in the era of pharmacogenomics.
    Flowers CR; Veenstra D
    Pharmacoeconomics; 2004; 22(8):481-93. PubMed ID: 15217305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The integration of personalized and systems medicine: bioinformatics support for pharmacogenomics and drug discovery.
    Yan Q
    Methods Mol Biol; 2008; 448():1-19. PubMed ID: 18370227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opening the gate for genomics data into clinical research: a use case in managing patients' DNA samples from the bench to drug development.
    Matteson S; Paulauskis J; Foisy S; Hall S; Duval M
    Pharmacogenomics; 2010 Nov; 11(11):1603-12. PubMed ID: 21121778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.